Novelty Nobility Inc. is a private clinical stage biotech company located in Pangyo, South Korea, and Boston, Massachusetts. We are currently focused on the research of novel angiogenesis targets and develop antibody-based therapeutics in ophthalmology and oncology, where angiogenesis plays a key pathogenic role.
Novelty Nobility, a unique name for a biotech company, stands for what we pursue – Novel Science, Noble Management. The emblem in the middle of our logo, which shapes a drug, symbolizes our belief that a new drug is born when novel science meets noble management.
Company Details
- Employees
- 12
- Founded
- -
- Address
- 6f, 227, Unjung-Ro, Seongnam-Si,gyeonggi-Do 13477,korea, Republic Of
- ji****@****ity.com
- Industry
- Biotechnology
- Website
- noveltynobility.com
- HQ
- Seongnam-si, Gyeonggi-do
Novelty Nobility Inc. Questions
Novelty Nobility Inc.'s website is noveltynobility.com
Novelty Nobility Inc.'s LinkedIn profile is https://www.linkedin.com/company/novelty-nobility
Novelty Nobility Inc. has
12 employees.
View email and phone details for 12
employees at Novelty Nobility Inc..
Novelty Nobility Inc.'s industry is
Biotechnology
Novelty Nobility Inc.'s top competitors are
Resalis Therapeutics,
Celldex,
Gc Cell,
Abion Inc.,
Yuhan Corporation,
Gc Biopharma (Gc녹십자),
Trexbio,
Trace Neuroscience,
Corxel Pharmaceuticals,
Aimed Bio Inc..
Novelty Nobility Inc.'s support email address is jin.cho@noveltynobility.com
Novelty Nobility Inc.'s categories are Biotechnology
Novelty Nobility Inc.'s founding year is 2017
